Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 493 results for "usfda"

140 images for usfda

Money Control, 1 day ago
Money Control, 4 days ago
Money Today, 4 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 2 weeks ago
Sify, 5 days ago
Money Control, 2 weeks ago

Cadila Healthcare advances after USFDA nod for oral suspension drug

Cadila Healthcare was up 1.26% to Rs 459.05 at 10:22 IST on BSE after the company said it has received final US drug regulator nod for an oral suspension drug.
 Business Standard7 hours ago Cadila Health up 3% on product launch USFDA nod to skin drug  Money Control1 month ago
Money Control

Jubilant Life Sciences gains 5% on USFDA approval for hypertension drug

This is second approval that company has received from the USFDA during the current financial year.
 Money Control1 day ago Jubilant Life receives USFDA nod for Olmesartan Medoxomil tablets  Myiris1 day ago Alembic Pharma gets USFDA approval for Olmesartan Medoxomil tablets  Myiris1 day ago Zydus Cadila receives USFDA's nod for Olmesartan Medoxomil tablets  Myiris1 day ago
[x]  
Money Control

USFDA exempts more products from import alert: Divis Labs

The regulator had earlier exempted 10 products, including Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium and BOC core succinate, from the import alert.
 Money Control3 days ago USFDA issues warning letter to Divis Labs for Vishakhapatnam unit  Business Standard4 days ago Divi's Labs' Vizag unit gets warning letter from USFDA  Business Standard4 days ago USFDA issues warning letter to Indoco Remedies' Goa plant  DNA2 weeks ago
[x]  
Sify

Sun Pharma share price falls 3% after Dadra unit gets 11 observations from USFDA

Dadra site is the biggest unit for the compay after Halol plant, for supplying drug in the United States.
 Money Control6 days ago Sun Pharma down on concerns about USFDA observations on Dadra unit  Sify6 days ago Sun Pharma slips on buzz unit gets USFDA observations  Business Standard6 days ago Aurobindo Pharma dips on USFDA procedural observations on Hyderabad unit  Business Standard1 week ago

USFDA issues 11 observations for Sun Pharma's Dadra facility

Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.
 DNA4 days ago Sun Pharma's Dadra facility receives 11 USFDA observations after inspection  Business Standard4 days ago Marksans Pharma intimates of USFDA inspection of its manufacturing facility at Goa  Business Standard2 weeks ago
Money Control

Dr Reddy#39;s Lab gains 3% on ‘no observations’ from USFDA for Srikakulam plant

The USFDA audit was conducted at its active pharmaceutical ingredient (API) Srikakulam special economic zone plant, from April 10-14.
 Money Control1 week ago Dr Reddy's Lab advances as USFDA completes audit of plant  Business Standard1 week ago Dr Reddy's gains as USFDA completes inspection of Srikakulam SEZ unit  Business Standard1 week ago Dr Reddys Laboratories announces successful USFDA inspection of its API Srikakulam Plant  Business Standard1 week ago
[x]  

Strides Shasun completes USFDA audit for API facility at Cuddalore

Strides Shasun completes USFDA audit for API facility at Cuddalore Source: IRIS | 25 Apr, 2017, 08.59AM Strides Shasun's API Facility at Cuddalore in the state of Tamil Nadu, has completed the audit by the US Food and Drug Administration (USFDA) with zero 483 ...
 Myiris1 day ago Strides Shasun's Cuddalore plant completes USFDA inspection  DNA3 days ago
Money Control

Orchid Pharma gets EIR from USFDA for Tamil Nadu plant

Drug firm Orchid Pharma today said the US health regulator has issued establishment inspection report (EIR) for its manufacturing facility in Tamil Nadu.
 DNA1 week ago Shilpa Medicare receives EIR from USFDA for Raichur facility  Myiris1 week ago Shilpa Medicare provides update on USFDA inspection of its API manufacturing facility at Raichur, Karnataka  Business Standard2 weeks ago Shilpa Medicare gets EIR from USFDA for Raichur facilities  DNA2 weeks ago
[x]  

Aurobindo Pharma down 4% on USFDA observations for Hyd unit

Shares of Aurobindo Pharma today fell by nearly 4 per cent after the company said that US health regulator has issued observations for its Unit III formulations facility in Hyderabad. The stock went down by 3.53 per cent to end at Rs 640.20 on BSE. During the ...
 Business Standard1 week ago Sun Pharma shares down 3%; m-cap dips by Rs 5,004 cr  DNA2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less